Have you or your loved ones been diagnosed with atrial fibrillation?

You may be eligible to participate in a atrial fibrillation clinical trial.

Have you or your loved ones been diagnosed with atrial fibrillation? You may be eligible to participate in a atrial fibrillation clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Atrial Fibrillation Clinical Trial in Maastricht
NCT01090362 | Observational

Have you or your loved ones been diagnosed with atrial fibrillation?

You may be eligible to participate in a atrial fibrillation clinical trial.

Have you or your loved ones been diagnosed with atrial fibrillation? You may be eligible to participate in a atrial fibrillation clinical trial.

Completed

Male & Female

18 Years +

This study has recruited 57250 Participants

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF Registry) is a non-interventional, observational study that characterized a global population of non-valvular atrial fibrillation patients. The registry was used to document global baseline characteristics, current treatment strategies and outcome measures. Characterisation of a number of AF sub-populations was also completed. GARFIELD-AF is an independent academic research initiative sponsored by the Thrombosis Research Institute (London, UK) and supported by an unrestricted research grant from Bayer AG (Berlin, Germany).